Spark Therapeutics put in application as it published positive phase 3 clinical trial results

NICE guidance recommends the use of Humira for the treatment of eye condition

Ophthalmic drugs remain the preferred approach to treat common eye disorders, from dry eye syndrome to glaucoma and AMD, forecast suggests

New research finds severe uveitis patients respond better to long-term treatment with oral medication than regional therapies

Patients with Graves’ disease report a significant reduction in eye symptoms after treatment with teprotumumab as part of a clinical trial

Poppers have been connected with impaired central vision, blurriness and blind spots in a new study

A dual drug combination holds promise for the treatment of diabetic retinopathy

Switching anti-VEGF drugs if a patient does not show a good response may not always be the best idea, study finds

Regular cannabis consumption appears to alter users’ vision

A new drug, currently in clinical trials, could potentially treat both macular oedema and wet AMD